col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

MDPI AG: International Journal of Molecular Sciences
  original article Date Title Authors   All Authors
1 [GO] 2021―Sep―17 Increased Autotaxin Levels in Severe COVID-19, Correlating with IL-6 Levels, Endothelial Dysfunction Biomarkers, and Impaired Functions of Dendritic Cells Ioanna Nikitopoulou, Dionysios Fanidis, Konstantinos Ntatsoulis, Panagiotis Moulos, George Mpekoulis, Maria Evangelidou, et al. (+12)
2 [GO] 2021―Sep―17 Vitamin D and Platelets: A Menacing Duo in COVID-19 and Potential Relation to Bone Remodeling Francesca Salamanna, Melania Maglio, Maria Sartori, Maria Paola Landini, Milena Fini
3 [GO] 2021―Sep―14 Tumor Necrosis Factor-Alpha Exacerbates Viral Entry in SARS-CoV2-Infected iPSC-Derived Cardiomyocytes Chiu-Yang Lee, Chih-Heng Huang, Elham Rastegari, Vimalan Rengganaten, Ping-Cheng Liu, Ping-Hsing Tsai, et al. (+12)
4 [GO] 2021―Sep―13 Virtual Alanine Scan of the Main Protease Active Site in Severe Acute Respiratory Syndrome Coronavirus 2 Tomoki Nakayoshi, Koichi Kato, Eiji Kurimoto, Akifumi Oda
5 [GO] 2021―Sep―10 The Se-S Bond Formation in the Covalent Inhibition Mechanism of SARS-CoV-2 Main Protease by Ebselen-like Inhibitors: A Computational Study Angela Parise, Isabella Romeo, Nino Russo, Tiziana Marino
6 [GO] 2021―Sep―09 Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19 Samar Rezq, Alexandra M. Huffman, Jelina Basnet, Licy L. Yanes Cardozo, Damian G. Romero
7 [GO] 2021―Sep―07 Computational Methods to Study Human Transcript Variants in COVID-19 Infected Lung Cancer Cells Jiao Sun, Naima Ahmed Fahmi, Heba Nassereddeen, Sze Cheng, Irene Martinez, Deliang Fan, et al. (+2)
8 [GO] 2021―Sep―06 Pharmacokinetic Drug-Drug Interactions among Antiepileptic Drugs, Including CBD, Drugs Used to Treat COVID-19 and Nutrients Marta Karaźniewicz-Łada, Anna K. Główka, Aniceta A. Mikulska, Franciszek K. Główka
9 [GO] 2021―Sep―02 The Serum Metabolome of Moderate and Severe COVID-19 Patients Reflects Possible Liver Alterations Involving Carbon and Nitrogen Metabolism Marianna Caterino, Michele Costanzo, Roberta Fedele, Armando Cevenini, Monica Gelzo, Alessandro Di Minno, et al. (+14)
10 [GO] 2021―Sep―02 Antimicrobial Face Shield: Next Generation of Facial Protective Equipment against SARS-CoV-2 and Multidrug-Resistant Bacteria Alberto Tuñón-Molina, Miguel Martí, Yukiko Muramoto, Takeshi Noda, Kazuo Takayama, Ángel Serrano-Aroca
11 [GO] 2021―Aug―31 Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease Adewale Oluwaseun Fadaka, Nicole Remaliah Samantha Sibuyi, Darius Riziki Martin, Ashwil Klein, Abram Madiehe, Mervin Meyer
12 [GO] 2021―Aug―31 Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential Anti SARS-CoV-2: Molecular Modelling, Synthesis and Bioactivity Evaluation Simone Di Micco, Simona Musella, Marina Sala, Maria C. Scala, Graciela Andrei, Robert Snoeck, et al. (+3)
13 [GO] 2021―Aug―27 Epigenetic Clocks Are Not Accelerated in COVID-19 Patients Julia Franzen, Selina Nüchtern, Vithurithra Tharmapalan, Margherita Vieri, Miloš Nikolić, Yang Han, et al. (+7)
14 [GO] 2021―Aug―26 SARS-CoV-2 Impairs Dendritic Cells and Regulates DC-SIGN Gene Expression in Tissues Guoshuai Cai, Mulong Du, Yohan Bossé, Helmut Albrecht, Fei Qin, Xizhi Luo, et al. (+8)
15 [GO] 2021―Aug―26 Phosphorylation of SARS-CoV-2 Orf9b Regulates Its Targeting to Two Binding Sites in TOM70 and Recruitment of Hsp90 Lukas Brandherm, Antonio Mario Kobaš, Mara Klöhn, Yannick Brüggemann, Stephanie Pfaender, Joachim Rassow, Sebastian Kreimendahl
16 [GO] 2021―Aug―26 The Role of the PFNA Operon of Bifidobacteria in the Recognition of Host’s Immune Signals: Prospects for the Use of the FN3 Protein in the Treatment of COVID-19 Venera Z. Nezametdinova, Roman A. Yunes, Marina S. Dukhinova, Maria G. Alekseeva, Valery N. Danilenko
17 [GO] 2021―Aug―25 Possible Link between Higher Transmissibility of Alpha, Kappa and Delta Variants of SARS-CoV-2 and Increased Structural Stability of Its Spike Protein and hACE2 Affinity Vipul Kumar, Jasdeep Singh, Seyed E. Hasnain, Durai Sundar
18 [GO] 2021―Aug―25 Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations Bilal Ahmad, Maria Batool, Qurat ul Ain, Moon Suk Kim, Sangdun Choi
19 [GO] 2021―Aug―23 Putative Role of Vitamin D for COVID-19 Vaccination Sheng-Kang Chiu, Kuo-Wang Tsai, Chia-Chao Wu, Cai-Mei Zheng, Chung-Hsiang Yang, Wan-Chung Hu, et al. (+3)
20 [GO] 2021―Aug―23 SARS-CoV-2 Proteins Bind to Hemoglobin and Its Metabolites Guilherme C. Lechuga, Franklin Souza-Silva, Carolina Q. Sacramento, Monique R. O. Trugilho, Richard H. Valente, Paloma Napoleão-Pêgo, et al. (+9)
21 [GO] 2021―Aug―23 Cell-Free Hemoglobin Does Not Attenuate the Effects of SARS-CoV-2 Spike Protein S1 Subunit in Pulmonary Endothelial Cells Sirsendu Jana, Michael R. Heaven, Abdu I. Alayash
22 [GO] 2021―Aug―23 Small Structural Proteins E and M Render the SARS-CoV-2 Pseudovirus More Infectious and Reveal the Phenotype of Natural Viral Variants Hsin-I Wang, Zih-Shiuan Chuang, Yu-Ting Kao, Yi-Ling Lin, Jian-Jong Liang, Chun-Che Liao, et al. (+3)
23 [GO] 2021―Aug―20 Adaptive Immunity and the Risk of Autoreactivity in COVID-19 Rhiane Moody, Kirsty Wilson, Katie L. Flanagan, Anthony Jaworowski, Magdalena Plebanski
24 [GO] 2021―Aug―20 “Molecular Masks” for ACE2 to Effectively and Safely Block SARS-CoV-2 Virus Entry Satya Prakash Shukla, Kwang Bog Cho, Vineeta Rustagi, Xiang Gao, Xinping Fu, Shaun Xiaoliu Zhang, et al. (+2)
25 [GO] 2021―Aug―18 Neutrophil Extracellular Traps (NETs) in Severe SARS-CoV-2 Lung Disease Monika Szturmowicz, Urszula Demkow
26 [GO] 2021―Aug―18 Oxidative Inactivation of SARS-CoV-2 on Photoactive AgNPs@TiO2 Ceramic Tiles Ridha Djellabi, Nicoletta Basilico, Serena Delbue, Sarah D’Alessandro, Silvia Parapini, Giuseppina Cerrato, et al. (+3)
27 [GO] 2021―Aug―18 Possible Use of Phytochemicals for Recovery from COVID-19-Induced Anosmia and Ageusia Sachiko Koyama, Kenji Kondo, Rumi Ueha, Hideki Kashiwadani, Thomas Heinbockel
28 [GO] 2021―Aug―18 Clearance of the SARS-CoV-2 Virus in an Immunocompromised Patient Mediated by Convalescent Plasma without B-Cell Recovery Maamoun Basheer, Elias Saad, Orly Laskar, Ofir Schuster, Hagai Rechnitzer, Simona Zisman-Rozen, et al. (+2)
29 [GO] 2021―Aug―13 Molecular Dynamics Studies on the Structural Characteristics for the Stability Prediction of SARS-CoV-2 Kwang-Eun Choi, Jeong-Min Kim, JeeEun Rhee, Ae Kyung Park, Eun-Jin Kim, Nam Sook Kang
30 [GO] 2021―Aug―13 RT-qPCR Diagnostics: The “Drosten” SARS-CoV-2 Assay Paradigm Stephen Bustin, Sara Kirvell, Jim F. Huggett, Tania Nolan
31 [GO] 2021―Aug―12 Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and Therapy Maria Narożna, Błażej Rubiś
32 [GO] 2021―Aug―12 SARS-CoV-2: Understanding the Transcriptional Regulation of ACE2 and TMPRSS2 and the Role of Single Nucleotide Polymorphism (SNP) at Codon 72 of p53 in the Innate Immune Response against Virus Infection Niraj Lodhi, Rubi Singh, Satya Prakash Rajput, Quaiser Saquib
33 [GO] 2021―Aug―11 Melatonin as a Potential Adjuvant Treatment for COVID-19 beyond Sleep Disorders Adam Wichniak, Aleksander Kania, Mariusz Siemiński, Wiesław Jerzy Cubała
34 [GO] 2021―Aug―10 Geraniin Inhibits the Entry of SARS-CoV-2 by Blocking the Interaction between Spike Protein RBD and Human ACE2 Receptor Young Soo Kim, Hwan-Suck Chung, Sang Gyun Noh, Bonggi Lee, Hae Young Chung, Jang-Gi Choi
35 [GO] 2021―Aug―09 Selenium Deficiency Due to Diet, Pregnancy, Severe Illness, or COVID-19-A Preventable Trigger for Autoimmune Disease Lutz Schomburg
36 [GO] 2021―Aug―09 Novel Nested-Seq Approach for SARS-CoV-2 Real-Time Epidemiology and In-Depth Mutational Profiling in Wastewater Margaritis Avgeris, Panagiotis G. Adamopoulos, Aikaterini Galani, Marieta Xagorari, Dimitrios Gourgiotis, Ioannis P. Trougakos, et al. (+4)
37 [GO] 2021―Aug―09 Interactions of Spike-RBD of SARS-CoV-2 and Platelet Factor 4: New Insights in the Etiopathogenesis of Thrombosis Margherita Passariello, Cinzia Vetrei, Felice Amato, Claudia De Lorenzo
38 [GO] 2021―Aug―06 Severe COVID-19 Patients Show an Increase in Soluble TNFR1 and ADAM17, with a Relationship to Mortality Yadira Palacios, Andy Ruiz, Lucero Ramón-Luing, Ranferi Ocaña-Guzman, Omar Barreto-Rodriguez, Anahí Sánchez-Monciváis, et al. (+12)
39 [GO] 2021―Aug―02 Role of the Renin-Angiotensin-Aldosterone and Kinin-Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID Samantha L. Cooper, Eleanor Boyle, Sophie R. Jefferson, Calum R. A. Heslop, Pirathini Mohan, Gearry G. J. Mohanraj, et al. (+4)
40 [GO] 2021―Jul―30 Mitochondrial Modulations, Autophagy Pathways Shifts in Viral Infections: Consequences of COVID-19 Shailendra Pratap Singh, Salomon Amar, Pinky Gehlot, Sanjib K. Patra, Navjot Kanwar, Abhinav Kanwal
41 [GO] 2021―Jul―30 The Effects of Aβ1-42 Binding to the SARS-CoV-2 Spike Protein S1 Subunit and Angiotensin-Converting Enzyme 2 John Tsu-An Hsu, Chih-Feng Tien, Guann-Yi Yu, Santai Shen, Yi-Hsuan Lee, Pei-Chien Hsu, et al. (+4)
42 [GO] 2021―Jul―28 Acute Kidney Injury in COVID-19 Marta Głowacka, Sara Lipka, Ewelina Młynarska, Beata Franczyk, Jacek Rysz
43 [GO] 2021―Jul―28 SARS-CoV-2 Infected Pediatric Cerebral Cortical Neurons: Transcriptomic Analysis and Potential Role of Toll-like Receptors in Pathogenesis Agnese Gugliandolo, Luigi Chiricosta, Valeria Calcaterra, Mara Biasin, Gioia Cappelletti, Stephana Carelli, et al. (+5)
44 [GO] 2021―Jul―27 The Good and Bad of Nrf2: An Update in Cancer and New Perspectives in COVID-19 Sonia Emanuele, Adriana Celesia, Antonella D’Anneo, Marianna Lauricella, Daniela Carlisi, Anna De Blasio, Michela Giuliano
45 [GO] 2021―Jul―27 Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection Luc Rochette, Steliana Ghibu
46 [GO] 2021―Jul―27 An Overview of Adipose Tissue ACE2 Modulation by Diet and Obesity. Potential Implications in COVID-19 Infection and Severity Saioa Gómez-Zorita, Iñaki Milton-Laskibar, Laura García-Arellano, Marcela González, María P. Portillo
47 [GO] 2021―Jul―26 Inflammatory Response in COVID-19 Patients Resulting from the Interaction of the Inflammasome and SARS-CoV-2 So Yeong Cheon, Bon-Nyeo Koo
48 [GO] 2021―Jul―26 Perspective of the Relationship between the Susceptibility to Initial SARS-CoV-2 Infectivity and Optimal Nasal Conditioning of Inhaled Air Ranjan Ramasamy
49 [GO] 2021―Jul―26 The Role of P-Selectin in COVID-19 Coagulopathy: An Updated Review Chiara Agrati, Alessandra Sacchi, Eleonora Tartaglia, Alessandra Vergori, Roberta Gagliardini, Alessandra Scarabello, Michele Bibas
50 [GO] 2021―Jul―26 Boosted Pro-Inflammatory Activity in Human PBMCs by Lipopolysaccharide and SARS-CoV-2 Spike Protein Is Regulated by α-1 Antitrypsin Srinu Tumpara, Anna R. Gründing, Kokilavani Sivaraman, Sabine Wrenger, Beata Olejnicka, Tobias Welte, et al. (+5)
51 [GO] 2021―Jul―21 Diabetic Nephropathy and COVID-19: The Potential Role of Immune Actors Diane Mourad, Nadim S. Azar, Sami T. Azar
52 [GO] 2021―Jul―19 Cigarette Smoke Stimulates SARS-CoV-2 Internalization by Activating AhR and Increasing ACE2 Expression in Human Gingival Epithelial Cells Cassio Luiz Coutinho Almeida-da-Silva, Harmony Matshik Dakafay, Kaitlyn Liu, David M. Ojcius
53 [GO] 2021―Jul―19 Support Vector Machine as a Supervised Learning for the Prioritization of Novel Potential SARS-CoV-2 Main Protease Inhibitors Nedra Mekni, Claudia Coronnello, Thierry Langer, Maria De Rosa, Ugo Perricone
54 [GO] 2021―Jul―16 Therapy of Type 2 Diabetes in Patients with SARS-CoV-2 Infection Weronika Bielka, Agnieszka Przezak, Andrzej Pawlik
55 [GO] 2021―Jul―15 Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes) Evgenii Gusev, Alexey Sarapultsev, Desheng Hu, Valeriy Chereshnev
56 [GO] 2021―Jul―14 Extension of Collagen Deposition in COVID-19 Post Mortem Lung Samples and Computed Tomography Analysis Findings Lorenzo Ball, Emanuela Barisione, Luca Mastracci, Michela Campora, Delfina Costa, Chiara Robba, et al. (+8)
57 [GO] 2021―Jul―13 Oxidative Stress and Inflammatory Biomarkers for the Prediction of Severity and ICU Admission in Unselected Patients Hospitalized with COVID-19 Morgane Ducastel, Camille Chenevier-Gobeaux, Yassine Ballaa, Jean-François Meritet, Michel Brack, Nicolas Chapuis, et al. (+6)
58 [GO] 2021―Jul―13 COVID-19 in Children: Expressions of Type I/II/III Interferons, TRIM28, SETDB1, and Endogenous Retroviruses in Mild and Severe Cases Pier-Angelo Tovo, Silvia Garazzino, Valentina Daprà, Giulia Pruccoli, Cristina Calvi, Federica Mignone, et al. (+8)
59 [GO] 2021―Jul―13 Role of Extracellular Vimentin in Cancer-Cell Functionality and Its Influence on Cell Monolayer Permeability Changes Induced by SARS-CoV-2 Receptor Binding Domain Divyendu Goud Thalla, Philipp Jung, Markus Bischoff, Franziska Lautenschläger
60 [GO] 2021―Jul―12 Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion Mohd Zulkifli Salleh, Jeremy P. Derrick, Zakuan Zainy Deris
61 [GO] 2021―Jul―05 Conventional and Unconventional Approaches for Innovative Drug Treatments in COVID-19: Looking Outside of Plato’s Cave George J. Kontoghiorghes, Annita Kolnagou, Stella Fetta, Christina N. Kontoghiorghe
62 [GO] 2021―Jul―01 Possible Link between SARS-CoV-2 Infection and Parkinson’s Disease: The Role of Toll-Like Receptor 4 Carmela Conte
63 [GO] 2021―Jul―01 Molecular Mechanisms of Palmitic Acid Augmentation in COVID-19 Pathologies Christie Joshi, Viren Jadeja, Heping Zhou
64 [GO] 2021―Jul―01 Albumin Infusion in Critically Ill COVID-19 Patients: Hemodilution and Anticoagulation Giuliano Ramadori
65 [GO] 2021―Jun―30 Structure-Based Virtual Screening Reveals Ibrutinib and Zanubrutinib as Potential Repurposed Drugs against COVID-19 Satyavani Kaliamurthi, Gur�an Selvaraj, Chandrabose Selvaraj, Sanjeev Kumar Singh, Dong-Qing Wei, Gilles H. Peslherbe
66 [GO] 2021―Jun―30 Identification of 13 Guanidinobenzoyl- or Aminidinobenzoyl-Containing Drugs to Potentially Inhibit TMPRSS2 for COVID-19 Treatment Xiaoqiang Huang, Robin Pearce, Gilbert S. Omenn, Yang Zhang
67 [GO] 2021―Jun―30 Pathophysiology and Clinical Manifestations of COVID-19-Related Acute Kidney Injury-The Current State of Knowledge and Future Perspectives Iwona Smarz-Widelska, Ewelina Grywalska, Izabela Morawska, Alicja Forma, Adam Michalski, Sebastian Mertowski, et al. (+5)
68 [GO] 2021―Jun―30 Seleno-Functionalization of Quercetin Improves the Non-Covalent Inhibition of Mpro and Its Antiviral Activity in Cells against SARS-CoV-2 Francesca Mangiavacchi, Pawel Botwina, Elena Menichetti, Luana Bagnoli, Ornelio Rosati, Francesca Marini, et al. (+16)
69 [GO] 2021―Jun―29 C9orf72 Intermediate Repeats Confer Genetic Risk for Severe COVID-19 Pneumonia Independently of Age Isabella Zanella, Eliana Zacchi, Simone Piva, Massimiliano Filosto, Giada Beligni, Diana Alaverdian, et al. (+8)
70 [GO] 2021―Jun―29 Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators Daniela Ricci, Marilena Paola Etna, Fabiana Rizzo, Silvia Sandini, Martina Severa, Eliana Marina Coccia
71 [GO] 2021―Jun―29 Does the SARS-CoV-2 Spike Protein Receptor Binding Domain Interact Effectively with the DPP4 (CD26) Receptor? A Molecular Docking Study Kirsten Cameron, Lina Rozano, Marco Falasca, Ricardo L. Mancera
72 [GO] 2021―Jun―28 COVID-19 Lockdowns May Reduce Resistance Genes Diversity in the Human Microbiome and the Need for Antibiotics João S. Rebelo, Célia P. F. Domingues, Francisco Dionisio, Manuel C. Gomes, Ana Botelho, Teresa Nogueira
73 [GO] 2021―Jun―28 De novo ssRNA Aptamers against the SARS-CoV-2 Main Protease: In Silico Design and Molecular Dynamics Simulation Francesco Morena, Chiara Argentati, Ilaria Tortorella, Carla Emiliani, Sabata Martino
74 [GO] 2021―Jun―28 Imatinib (STI571) Inhibits the Expression of Angiotensin-Converting Enzyme 2 and Cell Entry of the SARS-CoV-2-Derived Pseudotyped Viral Particles You-Zhe Lin, Yi-Chun Shen, Wan-Rong Wu, Wei-Jan Wang, Yuan-Liang Wang, Chen-Yuan Lin, et al. (+2)
75 [GO] 2021―Jun―28 Brain Mechanisms of COVID-19-Sleep Disorders Oxana Semyachkina-Glushkovskaya, Aysel Mamedova, Valeria Vinnik, Maria Klimova, Elena Saranceva, Vasily Ageev, et al. (+4)
76 [GO] 2021―Jun―23 Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms Huseyin C. Yalcin, Vijayakumar Sukumaran, Mahmoud Khatib A. A. Al-Ruweidi, Samar Shurbaji
77 [GO] 2021―Jun―23 Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels? Tomoshige Kino, Irina Burd, James H. Segars
78 [GO] 2021―Jun―23 Comparative Anti-Inflammatory Effects of Salix Cortex Extracts and Acetylsalicylic Acid in SARS-CoV-2 Peptide and LPS-Activated Human In Vitro Systems Nguyen Phan Khoi Le, Corinna Herz, João Victor Dutra Gomes, Nadja Förster, Kyriaki Antoniadou, Verena Karolin Mittermeier-Kleßinger, et al. (+4)
79 [GO] 2021―Jun―21 Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives Marios Sagris, Panagiotis Theofilis, Alexios S. Antonopoulos, Costas Tsioufis, Evangelos Oikonomou, Charalambos Antoniades, et al. (+3)
80 [GO] 2021―Jun―21 Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2 Valeria De Pasquale, Miriam Shasa Quiccione, Simona Tafuri, Luigi Avallone, Luigi Michele Pavone
81 [GO] 2021―Jun―18 SARS-CoV-2 Infection and Significance of Oral Health Management in the Era of “the New Normal with COVID-19 Kenichi Imai, Hajime Tanaka
82 [GO] 2021―Jun―18 Studying SARS-CoV-2 with Fluorescence Microscopy Lidia V. Putlyaeva, Konstantin A. Lukyanov
83 [GO] 2021―Jun―18 Estrogen Receptor Modulators in Viral Infections Such as SARS-CoV-2: Therapeutic Consequences Nikita Abramenko, Fréderic Vellieux, Petra Tesařová, Zdeněk Kejík, Robert Kaplánek, Lukáš Lacina, et al. (+6)
84 [GO] 2021―Jun―17 The Functional Consequences of the Novel Ribosomal Pausing Site in SARS-CoV-2 Spike Glycoprotein RNA Olga A. Postnikova, Sheetal Uppal, Weiliang Huang, Maureen A. Kane, Rafael Villasmil, Igor B. Rogozin, et al. (+2)
85 [GO] 2021―Jun―17 Antiviral Activity of Two Marine Carotenoids against SARS-CoV-2 Virus Entry In Silico and In Vitro Sung-Kun Yim, Inhee Kim, Boyd Warren, Jungwon Kim, Kyoojin Jung, Bosung Ku
86 [GO] 2021―Jun―17 More Is Always Better Than One: The N-Terminal Domain of the Spike Protein as Another Emerging Target for Hampering the SARS-CoV-2 Attachment to Host Cells Sonia Di Gaetano, Domenica Capasso, Pietro Delre, Luciano Pirone, Michele Saviano, Emilia Pedone, Giuseppe Felice Mangiatordi
87 [GO] 2021―Jun―07 Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors Alessia Mongelli, Veronica Barbi, Michela Gottardi Zamperla, Sandra Atlante, Luana Forleo, Marialisa Nesta, et al. (+11)
88 [GO] 2021―Jun―07 In Silico and In Vitro Analyses Validate Human MicroRNAs Targeting the SARS-CoV-2 3′-UTR María Asunción Barreda-Manso, Manuel Nieto-Díaz, Altea Soto, Teresa Muñoz-Galdeano, David Reigada, Rodrigo M. Maza
89 [GO] 2021―Jun―07 Nucleic Acid Testing of SARS-CoV-2 Hee Min Yoo, Il-Hwan Kim, Seil Kim
90 [GO] 2021―Jun―01 Extracellular Vesicles: Versatile Nanomediators, Potential Biomarkers and Therapeutic Agents in Atherosclerosis and COVID-19-Related Thrombosis Adriana Georgescu, Maya Simionescu
91 [GO] 2021―Jun―01 Multifaced Roles of HDL in Sepsis and SARS-CoV-2 Infection: Renal Implications Alessandra Stasi, Rossana Franzin, Marco Fiorentino, Enrico Squiccimarro, Giuseppe Castellano, Loreto Gesualdo
92 [GO] 2021―Jun―01 A Screening of the MMV Pandemic Response Box Reveals Epetraborole as A New Potent Inhibitor against Mycobacterium abscessus Taeho Kim, Bui-Thi-Bich Hanh, Boeun Heo, Nguyenthanh Quang, Yujin Park, Jihyeon Shin, et al. (+4)
93 [GO] 2021―Jun―01 Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses Morvarid Siri, Sanaz Dastghaib, Mozhdeh Zamani, Nasim Rahmani-Kukia, Kiarash Roustai Geraylow, Shima Fakher, et al. (+6)
94 [GO] 2021―May―31 The Significance of COVID-19 Immunological Status in Severe Neurological Complications and Multiple Sclerosis-A Literature Review Joanna Kulikowska, Agnieszka Kulczyńska-Przybik, Barbara Mroczko, Alina Kułakowska
95 [GO] 2021―May―28 The Immunological Role of the Placenta in SARS-CoV-2 Infection-Viral Transmission, Immune Regulation, and Lactoferrin Activity Iwona Bukowska-Ośko, Marta Popiel, Paweł Kowalczyk
96 [GO] 2021―May―28 Detection of SARS-CoV-2 RNA by a Multiplex Reverse-Transcription Loop-Mediated Isothermal Amplification Coupled with Melting Curves Analysis Igor P. Oscorbin, Georgiy Yu. Shevelev, Ksenia A. Pronyaeva, Andrey A. Stepanov, Darya V. Shamovskaya, Olga V. Mishukova, et al. (+2)
97 [GO] 2021―May―26 Induction of the Proinflammatory Chemokine Interleukin-8 Is Regulated by Integrated Stress Response and AP-1 Family Proteins Activated during Coronavirus Infection Qing Chun Zhu, Shumin Li, Li Xia Yuan, Rui Ai Chen, Ding Xiang Liu, To Sing Fung
98 [GO] 2021―May―26 Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19? Changbo Qu, Gwenny M. Fuhler, Yihang Pan
99 [GO] 2021―May―24 Possible Beneficial Actions of Caffeine in SARS-CoV-2 Bianca S. Romero-Martínez, Luis M. Montaño, Héctor Solís-Chagoyán, Bettina Sommer, Gemma Lizbeth Ramírez-Salinas, Gloria E. Pérez-Figueroa, Edgar Flores-Soto
100 [GO] 2021―May―21 Can the COVID-19 Pandemic Disrupt the Current Drug Development Practices? Jung-Hyun Won, Howard Lee
101 [GO] 2021―May―21 The Molecular Basis of COVID-19 Pathogenesis, Conventional and Nanomedicine Therapy Shirin Kouhpayeh, Laleh Shariati, Maryam Boshtam, Ilnaz Rahimmanesh, Mina Mirian, Yasaman Esmaeili, et al. (+7)
102 [GO] 2021―May―21 Existing Drugs Considered as Promising in COVID-19 Therapy Edyta Janik, Marcin Niemcewicz, Marcin Podogrocki, Joanna Saluk-Bijak, Michal Bijak
103 [GO] 2021―May―20 The Emerging Role of Neutrophils in the Pathogenesis of Thrombosis in COVID-19 Valeria Iliadi, Ina Konstantinidou, Konstantina Aftzoglou, Sergios Iliadis, Theocharis G. Konstantinidis, Christina Tsigalou
104 [GO] 2021―May―20 Regulatory Noncoding and Predicted Pathogenic Coding Variants of CCR5 Predispose to Severe COVID-19 Sueva Cantalupo, Vito Alessandro Lasorsa, Roberta Russo, Immacolata Andolfo, Giuseppe D’Alterio, Barbara Eleni Rosato, et al. (+15)
105 [GO] 2021―May―19 Contribution of Syndecans to the Cellular Entry of SARS-CoV-2 Anett Hudák, Annamária Letoha, László Szilák, Tamás Letoha
106 [GO] 2021―May―17 Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D Ming-Yieh Peng, Wen-Chih Liu, Jing-Quan Zheng, Chien-Lin Lu, Yi-Chou Hou, Cai-Mei Zheng, et al. (+3)
107 [GO] 2021―May―13 Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19 Tatsuya Maruhashi, Yukihito Higashi
108 [GO] 2021―May―10 Does Genetic Predisposition Contribute to the Exacerbation of COVID-19 Symptoms in Individuals with Comorbidities and Explain the Huge Mortality Disparity between the East and the West? Naoki Yamamoto, Rain Yamamoto, Yasuo Ariumi, Masashi Mizokami, Kunitada Shimotohno, Hiroshi Yoshikura
109 [GO] 2021―May―07 High Levels of the Cleaved Form of Galectin-9 and Osteopontin in the Plasma Are Associated with Inflammatory Markers That Reflect the Severity of COVID-19 Pneumonia Gaowa Bai, Daisuke Furushima, Toshiro Niki, Takashi Matsuba, Yosuke Maeda, Atsushi Takahashi, et al. (+2)
110 [GO] 2021―May―07 IgM and IgG Immunoreactivity of SARS-CoV-2 Recombinant M Protein Zorana Lopandić, Isidora Protić-Rosić, Aleksandra Todorović, Sofija Glamočlija, Marija Gnjatović, Danica Ćujic, Marija Gavrović-Jankulović
111 [GO] 2021―May―02 The Interference between SARS-CoV-2 and Tyrosine Kinase Receptor Signaling in Cancer Oana-Stefana Purcaru, Stefan-Alexandru Artene, Edmond Barcan, Cristian Adrian Silosi, Ilona Stanciu, Suzana Danoiu, et al. (+3)
112 [GO] 2021―Apr―30 Metabolic Signatures Associated with Severity in Hospitalized COVID-19 Patients Judith Marín-Corral, Jose Rodríguez-Morató, Alex Gomez-Gomez, Sergi Pascual-Guardia, Rosana Muñoz-Bermúdez, Anna Salazar-Degracia, et al. (+6)
113 [GO] 2021―Apr―29 ACE2 Is an Adjacent Element of Atherosclerosis and COVID-19 Pathogenesis Anastasia V. Poznyak, Evgeny E. Bezsonov, Ali H. Eid, Tatyana V. Popkova, Ludmila V. Nedosugova, Antonina V. Starodubova, Alexander N. Orekhov
114 [GO] 2021―Apr―27 Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review Aneta Aleksova, Giulia Gagno, Gianfranco Sinagra, Antonio Paolo Beltrami, Milijana Janjusevic, Giuseppe Ippolito, et al. (+3)
115 [GO] 2021―Apr―27 Dysregulation of the Renin-Angiotensin-Aldosterone System (RAA) in Patients Infected with SARS-CoV-2-Possible Clinical Consequences Agnieszka Dettlaff-Pokora, Julian Swierczynski
116 [GO] 2021―Apr―27 PIMS-TS, the New Paediatric Systemic Inflammatory Disease Related to Previous Exposure to SARS-CoV-2 Infection-“Rheumatic Fever” of the 21st Century? Violetta Opoka-Winiarska, Ewelina Grywalska, Jacek Roliński
117 [GO] 2021―Apr―26 SARS-CoV-2 Viral Entry Proteins in Hyperandrogenemic Female Mice: Implications for Women with PCOS and COVID-19 Alexandra M. Huffman, Samar Rezq, Jelina Basnet, Licy L. Yanes Cardozo, Damian G. Romero
118 [GO] 2021―Apr―19 COVID-19: Direct and Indirect Mechanisms of Statins Agnieszka Pawlos, Mateusz Niedzielski, Paulina Gorzelak-Pabiś, Marlena Broncel, Ewelina Woźniak
119 [GO] 2021―Apr―15 Pharmacological Modulators of Autophagy as a Potential Strategy for the Treatment of COVID-19 Gustavo José da Silva Pereira, Anderson Henrique França Figueredo Leão, Adolfo Garcia Erustes, Ingrid Beatriz de Melo Morais, Talita Aparecida de Moraes Vrechi, Lucas dos Santos Zamarioli, et al. (+9)
120 [GO] 2021―Apr―15 Cardiovascular Outcomes in the Acute Phase of COVID-19 Hiroki Nakano, Kazuki Shiina, Hirofumi Tomiyama
121 [GO] 2021―Apr―15 Neurological Complications of COVID-19: Underlying Mechanisms and Management Ghaydaa A. Shehata, Kevin C. Lord, Michaela C. Grudzinski, Mohamed Elsayed, Ramy Abdelnaby, Hatem A. Elshabrawy
122 [GO] 2021―Apr―12 SARS-CoV-2 Papain-Like Protease Potential Inhibitors-In Silico Quantitative Assessment Adam Stasiulewicz, Alicja W. Maksymiuk, Mai Lan Nguyen, Barbara Bełza, Joanna I. Sulkowska
123 [GO] 2021―Apr―08 Influence of Previous COVID-19 and Mastitis Infections on the Secretion of Brain-Derived Neurotrophic Factor and Nerve Growth Factor in Human Milk Veronique Demers-Mathieu, Dustin J. Hines, Rochelle M. Hines, Sirima Lavangnananda, Shawn Fels, Elena Medo
124 [GO] 2021―Apr―06 Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis Radha Gopalaswamy, Selvakumar Subbian
125 [GO] 2021―Mar―26 Ribosome-Profiling Reveals Restricted Post Transcriptional Expression of Antiviral Cytokines and Transcription Factors during SARS-CoV-2 Infection Marina R. Alexander, Aaron M. Brice, Petrus Jansen van Vuren, Christina L. Rootes, Leon Tribolet, Christopher Cowled, et al. (+2)
126 [GO] 2021―Mar―22 Susceptibility and Severity of Viral Infections in Obesity: Lessons from Influenza to COVID-19. Does Leptin Play a Role? Valeria Guglielmi, Luca Colangeli, Monica D’Adamo, Paolo Sbraccia
127 [GO] 2021―Mar―22 Exosomes from COVID-19 Patients Carry Tenascin-C and Fibrinogen-β in Triggering Inflammatory Signals in Cells of Distant Organ Subhayan Sur, Mousumi Khatun, Robert Steele, T. Scott Isbell, Ranjit Ray, Ratna B. Ray
128 [GO] 2021―Mar―22 Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro Hirofumi Ohashi, Feng Wang, Frank Stappenbeck, Kana Tsuchimoto, Chisa Kobayashi, Wakana Saso, et al. (+10)
129 [GO] 2021―Mar―22 Renin-Angiotensin-Aldosterone System: Friend or Foe-The Matter of Balance. Insight on History, Therapeutic Implications and COVID-19 Interactions Fedor Simko, Jaroslav Hrenak, Michaela Adamcova, Ludovit Paulis
130 [GO] 2021―Mar―19 Dietary and Protective Factors to Halt or Mitigate Progression of Autoimmunity, COVID-19 and Its Associated Metabolic Diseases Camillo Ricordi, Francesca Pacifici, Giacomo Lanzoni, Anna Teresa Palamara, Enrico Garaci, David Della-Morte
131 [GO] 2021―Mar―17 Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence Corrado Pelaia, Cecilia Calabrese, Eugenio Garofalo, Andrea Bruni, Alessandro Vatrella, Girolamo Pelaia
132 [GO] 2021―Mar―17 SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity Szu-Wei Huang, Sheng-Fan Wang
133 [GO] 2021―Mar―16 Fecal Microbiota Transplantation during and Post-COVID-19 Pandemic Negin Kazemian, Dina Kao, Sepideh Pakpour
134 [GO] 2021―Mar―15 Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis Raymond Chu, Charmaine van Eeden, Sneha Suresh, Wendy I. Sligl, Mohammed Osman, Jan Willem Cohen Tervaert
135 [GO] 2021―Mar―15 Metal-Bound Methisazone; Novel Drugs Targeting Prophylaxis and Treatment of SARS-CoV-2, a Molecular Docking Study Ahmed Abdelaal Ahmed Mahmoud M. Alkhatip, Michail Georgakis, Lucio R. Montero Valenzuela, Mohamed Hamza, Ehab Farag, Jaqui Hodgkinson, et al. (+12)
136 [GO] 2021―Mar―10 A Novel Computational Approach for the Discovery of Drug Delivery System Candidates for COVID-19 Taeheum Cho, Hyo-Sang Han, Junhyuk Jeong, Eun-Mi Park, Kyu-Sik Shim
137 [GO] 2021―Mar―08 Interactions of SARS-CoV-2 with the Blood-Brain Barrier Michelle A. Erickson, Elizabeth M. Rhea, Rachel C. Knopp, William A. Banks
138 [GO] 2021―Mar―08 Towards Quantitative and Standardized Serological and Neutralization Assays for COVID-19 Linhua Tian, Elzafir B. Elsheikh, Paul N. Patrone, Anthony J. Kearsley, Adolfas K. Gaigalas, Sarah Inwood, et al. (+3)
139 [GO] 2021―Mar―05 The Role of Immunogenetics in COVID-19 Fanny Pojero, Giuseppina Candore, Calogero Caruso, Danilo Di Bona, David A. Groneberg, Mattia E. Ligotti, et al. (+2)
140 [GO] 2021―Mar―05 Population-Predicted MHC Class II Epitope Presentation of SARS-CoV-2 Structural Proteins Correlates to the Case Fatality Rates of COVID-19 in Different Countries Chunguang Liang, Elena Bencurova, Eric Psota, Priya Neurgaonkar, Martina Prelog, Carsten Scheller, Thomas Dandekar
141 [GO] 2021―Mar―05 CNBP Binds and Unfolds In Vitro G-Quadruplexes Formed in the SARS-CoV-2 Positive and Negative Genome Strands Georgina Bezzi, Ernesto J. Piga, Andrés Binolfi, Pablo Armas
142 [GO] 2021―Mar―01 Nutraceuticals in the Prevention of Viral Infections, Including COVID-19, among the Pediatric Population: A Review of the Literature Giuseppe Fabio Parisi, Giuseppe Carota, Carlo Castruccio Castracani, Mariarita Spampinato, Sara Manti, Maria Papale, et al. (+3)
143 [GO] 2021―Mar―01 COVID-19 and Diagnostic Testing for SARS-CoV-2 by RT-qPCR-Facts and Fallacies Stephen Bustin, Reinhold Mueller, Gregory Shipley, Tania Nolan
144 [GO] 2021―Feb―27 SARS-CoV-2 Infection and Disease Modelling Using Stem Cell Technology and Organoids Marta Trevisan, Silvia Riccetti, Alessandro Sinigaglia, Luisa Barzon
145 [GO] 2021―Feb―22 Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions Robert Root-Bernstein
146 [GO] 2021―Feb―20 Computational Selectivity Assessment of Protease Inhibitors against SARS-CoV-2 André Fischer, Manuel Sellner, Karolina Mitusińska, Maria Bzówka, Markus A. Lill, Artur Góra, Martin Smieško
147 [GO] 2021―Feb―18 Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19 Barbara Malinowska, Marta Baranowska-Kuczko, Aleksandra Kicman, Eberhard Schlicker
148 [GO] 2021―Feb―17 Adjunctive Nutraceutical Therapies for COVID-19 Lalita Subedi, Stephanie Tchen, Bhakta Prasad Gaire, Bingren Hu, Kurt Hu
149 [GO] 2021―Feb―15 Neutralizing Human Antibodies against Severe Acute Respiratory Syndrome Coronavirus 2 Isolated from a Human Synthetic Fab Phage Display Library Yu Jung Kim, Min Ho Lee, Se-Ra Lee, Hyo-Young Chung, Kwangmin Kim, Tae Gyu Lee, Dae Young Kim
150 [GO] 2021―Feb―14 Bioactive Alkaloids from Genus Aspergillus: Mechanistic Interpretation of Their Antimicrobial and Potential SARS-CoV-2 Inhibitory Activity Using Molecular Modelling Fadia S. Youssef, Elham Alshammari, Mohamed L. Ashour
151 [GO] 2021―Feb―13 Platelet Lysate Nebulization Protocol for the Treatment of COVID-19 and Its Sequels: Proof of Concept and Scientific Rationale Maider Beitia, Diego Delgado, Pello Sánchez, Ana Vallejo de la Cueva, José Ramón Cugat, Mikel Sánchez
152 [GO] 2021―Feb―12 Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers Veronique Demers-Mathieu, Ciera DaPra, Gabrielle Mathijssen, David A. A. Sela, Kirsi M. M. Jarvinen, Antti Seppo, et al. (+2)
153 [GO] 2021―Feb―12 Detection of Coronaviruses Using RNA Toehold Switch Sensors Soan Park, Jeong Wook Lee
154 [GO] 2021―Feb―12 Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19 Markus Blaess, Lars Kaiser, Oliver Sommerfeld, René Csuk, Hans-Peter Deigner
155 [GO] 2021―Feb―12 The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis Angela Dziedzic, Joanna Saluk-Bijak, Elzbieta Miller, Marcin Niemcewicz, Michal Bijak
156 [GO] 2021―Feb―10 Understanding Viral Infection Mechanisms and Patient Symptoms for the Development of COVID-19 Therapeutics Hyung Muk Choi, Soo Youn Moon, Hyung In Yang, Kyoung Soo Kim
157 [GO] 2021―Feb―10 ERAP1 and ERAP2 Enzymes: A Protective Shield for RAS against COVID-19? Silvia D’Amico, Patrizia Tempora, Valeria Lucarini, Ombretta Melaiu, Stefania Gaspari, Mattia Algeri, Doriana Fruci
158 [GO] 2021―Feb―10 In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2-Spike RBD Interface Bruno O. Villoutreix, Vincent Calvez, Anne-Geneviève Marcelin, Abdel-Majid Khatib
159 [GO] 2021―Feb―09 Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis Sarah Seeherman, Yuichiro J. Suzuki
160 [GO] 2021―Feb―05 Tryptophan Metabolites and Aryl Hydrocarbon Receptor in Severe Acute Respiratory Syndrome, Coronavirus-2 (SARS-CoV-2) Pathophysiology George Anderson, Annalucia Carbone, Gianluigi Mazzoccoli
161 [GO] 2021―Feb―04 Comparison of Antiviral Activity of Gemcitabine with 2′-Fluoro-2′-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2 Yejin Jang, Jin Soo Shin, Myoung Kyu Lee, Eunhye Jung, Timothy An, Uk-Il Kim, et al. (+2)
162 [GO] 2021―Feb―04 Predicting Potential SARS-COV-2 Drugs-In Depth Drug Database Screening Using Deep Neural Network Framework SSnet, Classical Virtual Screening and Docking Nischal Karki, Niraj Verma, Francesco Trozzi, Peng Tao, Elfi Kraka, Brian Zoltowski
163 [GO] 2021―Jan―30 Pseudo-Dipeptide Bearing α,α-Difluoromethyl Ketone Moiety as Electrophilic Warhead with Activity against Coronaviruses Andrea Citarella, Davide Gentile, Antonio Rescifina, Anna Piperno, Barbara Mognetti, Giorgio Gribaudo, et al. (+4)
164 [GO] 2021―Jan―30 Predicting Potential SARS-COV-2 Drugs-In Depth Drug Database Screening Using Deep Neural Network Framework SSnet, Classical Virtual Screening and Docking Nischal Karki, Niraj Verma, Francesco Trozzi, Peng Tao, Elfi Kraka, Brian Zoltowski
165 [GO] 2021―Jan―29 Expression of the SARS-CoV-2 Receptor ACE2 and Proinflammatory Cytokines Induced by the Periodontopathic Bacterium Fusobacterium nucleatum in Human Respiratory Epithelial Cells Yuwa Takahashi, Norihisa Watanabe, Noriaki Kamio, Sho Yokoe, Ryuta Suzuki, Shuichi Sato, et al. (+2)
166 [GO] 2021―Jan―28 Summary of the Available Molecular Methods for Detection of SARS-CoV-2 during the Ongoing Pandemic Fabio Arena, Simona Pollini, Gian Maria Rossolini, Maurizio Margaglione
167 [GO] 2021―Jan―28 The Central Role of Fibrinolytic Response in COVID-19-A Hematologist’s Perspective Hau C. Kwaan, Paul F. Lindholm
168 [GO] 2021―Jan―26 Mediterranean Diet for the Prevention of Gestational Diabetes in the Covid-19 Era: Implications of Il-6 In Diabesity Anna Lucia Fedullo, Antonio Schiattarella, Maddalena Morlando, Anna Raguzzini, Elisabetta Toti, Pasquale De Franciscis, Ilaria Peluso
169 [GO] 2021―Jan―25 A Missing Link: Engagements of Dendritic Cells in the Pathogenesis of SARS-CoV-2 Infections Abdulaziz Alamri, Derek Fisk, Deepak Upreti, Sam K. P. Kung
170 [GO] 2021―Jan―20 Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells? Laura Kate Gadanec, Kristen Renee McSweeney, Tawar Qaradakhi, Benazir Ali, Anthony Zulli, Vasso Apostolopoulos
171 [GO] 2021―Jan―20 A Novel Approach to the Bioluminescent Detection of the SARS-CoV-2 ORF1ab Gene by Coupling Isothermal RNA Reverse Transcription Amplification with a Digital PCR Approach Zhongjie Fei, Rongbin Wei, Chu Cheng, Pengfeng Xiao
172 [GO] 2021―Jan―19 The Immunopathological and Histological Landscape of COVID-19-Mediated Lung Injury Giovanni Zarrilli, Valentina Angerilli, Gianluca Businello, Marta Sbaraglia, Giulia Traverso, Francesco Fortarezza, et al. (+6)
173 [GO] 2021―Jan―08 Mapping the SARS-CoV-2-Host Protein-Protein Interactome by Affinity Purification Mass Spectrometry and Proximity-Dependent Biotin Labeling: A Rational and Straightforward Route to Discover Host-Directed Anti-SARS-CoV-2 Therapeutics Rosa Terracciano, Mariaimmacolata Preianò, Annalisa Fregola, Corrado Pelaia, Tiziana Montalcini, Rocco Savino
174 [GO] 2021―Jan―01 Unpacking Pandora From Its Box: Deciphering the Molecular Basis of the SARS-CoV-2 Coronavirus Valerie Bríd O’Leary, Oliver James Dolly, Cyril Höschl, Marie Černa, Saak Victor Ovsepian
175 [GO] 2020―Dec―23 Multiple Recombination Events and Strong Purifying Selection at the Origin of SARS-CoV-2 Spike Glycoprotein Increased Correlated Dynamic Movements Massimiliano S. Tagliamonte, Nabil Abid, Stefano Borocci, Elisa Sangiovanni, David A. Ostrov, Sergei L. Kosakovsky Pond, et al. (+3)
176 [GO] 2020―Dec―22 The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic Jung-Hyun Won, Howard Lee
177 [GO] 2020―Dec―21 Vascular Endothelial Glycocalyx Damage in COVID-19 Minako Yamaoka-Tojo
178 [GO] 2020―Dec―16 Antimicrobial and Amyloidogenic Activity of Peptides. Can Antimicrobial Peptides Be Used against SARS-CoV-2? Stanislav R. Kurpe, Sergei Yu. Grishin, Alexey K. Surin, Alexander V. Panfilov, Mikhail V. Slizen, Saikat D. Chowdhury, Oxana V. Galzitskaya
179 [GO] 2020―Dec―15 Identification of Host Cellular Protein Substrates of SARS-COV-2 Main Protease Márió Miczi, Mária Golda, Balázs Kunkli, Tibor Nagy, József Tőzsér, János András Mótyán
180 [GO] 2020―Dec―07 The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection Jessica Maiuolo, Rocco Mollace, Micaela Gliozzi, Vincenzo Musolino, Cristina Carresi, Sara Paone, et al. (+9)
181 [GO] 2020―Dec―04 Interrelated Mechanism by Which the Methide Quinone Celastrol, Obtained from the Roots of Tripterygium wilfordii, Inhibits Main Protease 3CLpro of COVID-19 and Acts as Superoxide Radical Scavenger Francesco Caruso, Manrose Singh, Stuart Belli, Molly Berinato, Miriam Rossi
182 [GO] 2020―Dec―02 Establishment of Murine Hybridoma Cells Producing Antibodies against Spike Protein of SARS-CoV-2 Nadezhda V. Antipova, Tatyana D. Larionova, Andrei E. Siniavin, Maria A. Nikiforova, Vladimir A. Gushchin, Igor I. Babichenko, et al. (+3)
183 [GO] 2020―Nov―23 Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-19 Sara Schumann, Astrid Kaiser, Ferdinando Nicoletti, Katia Mangano, Paolo Fagone, Eduard van Wijk, et al. (+9)
184 [GO] 2020―Nov―17 The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19 Alessandro Bellis, Ciro Mauro, Emanuele Barbato, Bruno Trimarco, Carmine Morisco
185 [GO] 2020―Nov―17 Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2 Elettra Barberis, Sara Timo, Elia Amede, Virginia V. Vanella, Chiara Puricelli, Giuseppe Cappellano, et al. (+19)
186 [GO] 2020―Nov―09 Cardiovascular Active Peptides of Marine Origin with ACE Inhibitory Activities: Potential Role as Anti-Hypertensive Drugs and in Prevention of SARS-CoV-2 Infection Marco Festa, Clementina Sansone, Christophe Brunet, Fabio Crocetta, Luisa Di Paola, Michele Lombardo, et al. (+3)
187 [GO] 2020―Nov―05 Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2 Gennady Verkhivker
188 [GO] 2020―Nov―03 Erythrocyte, Platelet, Serum Ferritin, and P-Selectin Pathophysiology Implicated in Severe Hypercoagulation and Vascular Complications in COVID-19 Chantelle Venter, Johannes Andries Bezuidenhout, Gert Jacobus Laubscher, Petrus Johannes Lourens, Janami Steenkamp, Douglas B. Kell, Etheresia Pretorius
189 [GO] 2020―Oct―31 Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury Federico Biscetti, Maria Margherita Rando, Elisabetta Nardella, Andrea Leonardo Cecchini, Piergiorgio Bruno, Raffaele Landolfi, Andrea Flex
190 [GO] 2020―Oct―29 Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets Harry Karmouty-Quintana, Rajarajan A. Thandavarayan, Steven P. Keller, Sandeep Sahay, Lavannya M. Pandit, Bindu Akkanti
191 [GO] 2020―Oct―26 Interleukin-6: Molecule in the Intersection of Cancer, Ageing and COVID-19 Jan Brábek, Milan Jakubek, Fréderic Vellieux, Jiří Novotný, Michal Kolář, Lukáš Lacina, et al. (+5)
192 [GO] 2020―Oct―26 SARS-CoV-2/Renin-Angiotensin System: Deciphering the Clues for a Couple with Potentially Harmful Effects on Skeletal Muscle Andrea Gonzalez, Josué Orozco-Aguilar, Oscar Achiardi, Felipe Simon, Claudio Cabello-Verrugio
193 [GO] 2020―Oct―06 Crystal Structure of Non-Structural Protein 10 from Severe Acute Respiratory Syndrome Coronavirus-2 Annika Rogstam, Maria Nyblom, Signe Christensen, Celeste Sele, Vladimir O. Talibov, Therese Lindvall, et al. (+5)
194 [GO] 2020―Sep―29 Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19 Eileen M McGowan, Nahal Haddadi, Najah T. Nassif, Yiguang Lin
195 [GO] 2020―Sep―28 Role of SARS-CoV-2 in Altering the RNA-Binding Protein and miRNA-Directed Post-Transcriptional Regulatory Networks in Humans Rajneesh Srivastava, Swapna Vidhur Daulatabad, Mansi Srivastava, Sarath Chandra Janga
196 [GO] 2020―Sep―22 Imaging Diagnostics and Pathology in SARS-CoV-2-Related Diseases Manuel Scimeca, Nicoletta Urbano, Rita Bonfiglio, Manuela Montanaro, Elena Bonanno, Orazio Schillaci, Alessandro Mauriello
197 [GO] 2020―Sep―18 Stem Cells Secretome from Oral Tissue Could Represent a Promising Therapeutic Approach in COVID-19-Disease? Francesca Diomede, Guya D. Marconi, Luigia Fonticoli, Jacopo Pizzicannella, Oriana Trubiani
198 [GO] 2020―Sep―16 Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic Strategies Arun Samidurai, Anindita Das
199 [GO] 2020―Sep―15 SARS-CoV-2 Infection: A Role for S1P/S1P Receptor Signaling in the Nervous System? Elisabetta Meacci, Mercedes Garcia-Gil, Federica Pierucci
200 [GO] 2020―Sep―09 Smoking and COVID-19: Adding Fuel to the Flame Vivek K. Kashyap, Anupam Dhasmana, Andrew Massey, Sudhir Kotnala, Nadeem Zafar, Meena Jaggi, et al. (+2)
201 [GO] 2020―Sep―09 Improved Detection of Antibodies against SARS-CoV-2 by Microsphere-Based Antibody Assay Carol Ho-Yan Fong, Jian-Piao Cai, Thrimendra Kaushika Dissanayake, Lin-Lei Chen, Charlotte Yee-Ki Choi, Lok-Hin Wong, et al. (+11)
202 [GO] 2020―Sep―04 Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System Jairo Lumpuy-Castillo, Ana Lorenzo-Almorós, Ana María Pello-Lázaro, Carlos Sánchez-Ferrer, Jesús Egido, José Tuñón, et al. (+2)
203 [GO] 2020―Sep―03 The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19) Neelu Batra, Cristabelle De Souza, Jyoti Batra, Alan G. Raetz, Ai-Ming Yu
204 [GO] 2020―Sep―01 Natural Killer Cell Dysfunction and Its Role in COVID-19 Charmaine van Eeden, Lamia Khan, Mohammed S. Osman, Jan Willem Cohen Tervaert
205 [GO] 2020―Aug―27 Using All-Atom Potentials to Refine RNA Structure Predictions of SARS-CoV-2 Stem Loops Christina Bergonzo, Andrea L. Szakal
206 [GO] 2020―Aug―20 Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity Wakako Sakaguchi, Nobuhisa Kubota, Tomoko Shimizu, Juri Saruta, Shinya Fuchida, Akira Kawata, et al. (+4)
207 [GO] 2020―Aug―18 Deciphering SARS-CoV-2 Virologic and Immunologic Features Grégorie Lebeau, Damien Vagner, Étienne Frumence, Franck Ah-Pine, Xavier Guillot, Estelle Nobécourt, et al. (+2)
208 [GO] 2020―Aug―14 New Anti SARS-Cov-2 Targets for Quinoline Derivatives Chloroquine and Hydroxychloroquine Davide Gentile, Virginia Fuochi, Antonio Rescifina, Pio Maria Furneri
209 [GO] 2020―Aug―13 Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications Konstantinos Farsalinos, Elias Eliopoulos, Demetres D. Leonidas, Georgios E. Papadopoulos, Socrates Tzartos, Konstantinos Poulas
210 [GO] 2020―Aug―12 Obesity and COVID-19: Molecular Mechanisms Linking Both Pandemics Andreas Ritter, Nina-Naomi Kreis, Frank Louwen, Juping Yuan
211 [GO] 2020―Aug―10 SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells Rolando Cannalire, Irina Stefanelli, Carmen Cerchia, Andrea R. Beccari, Sveva Pelliccia, Vincenzo Summa
212 [GO] 2020―Aug―07 Development and Evaluation of Novel and Highly Sensitive Single-Tube Nested Real-Time RT-PCR Assays for SARS-CoV-2 Detection Cyril Chik-Yan Yip, Siddharth Sridhar, Kit-Hang Leung, Anthony Chin-Ki Ng, Kwok-Hung Chan, Jasper Fuk-Woo Chan, et al. (+5)
213 [GO] 2020―Aug―04 COVID-19: The Immune Responses and Clinical Therapy Candidates Sareh Zhand, Marie Saghaeian Jazi, Saeed Mohammadi, Roozbeh Tarighati Rasekhi, Ghassem Rostamian, Mohammad Reza Kalani, et al. (+3)
214 [GO] 2020―Aug―04 Use of Whole Genome Sequencing Data for a First in Silico Specificity Evaluation of the RT-qPCR Assays Used for SARS-CoV-2 Detection Mathieu Gand, Kevin Vanneste, Isabelle Thomas, Steven Van Gucht, Arnaud Capron, Philippe Herman, et al. (+2)
215 [GO] 2020―Aug―03 SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms Manuela Pennisi, Giuseppe Lanza, Luca Falzone, Francesco Fisicaro, Raffaele Ferri, Rita Bella
216 [GO] 2020―Jul―29 A Rapid, Simple, Inexpensive, and Mobile Colorimetric Assay COVID-19-LAMP for Mass On-Site Screening of COVID-19 Franklin Wang-Ngai Chow, Tony Tat-Yin Chan, Anthony Raymond Tam, Suhui Zhao, Weiming Yao, Joshua Fung, et al. (+21)
217 [GO] 2020―Jul―28 Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19? Mauro Giorgi, Silvia Cardarelli, Federica Ragusa, Michele Saliola, Stefano Biagioni, Giancarlo Poiana, et al. (+2)
218 [GO] 2020―Jul―28 Computational Studies of SARS-CoV-2 3CLpro: Insights from MD Simulations Alessandro Grottesi, Neva Bešker, Andrew Emerson, Candida Manelfi, Andrea R. Beccari, Francesco Frigerio, et al. (+3)
219 [GO] 2020―Jul―22 Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes Corlia Grobler, Siphosethu C. Maphumulo, L. Mireille Grobbelaar, Jhade C. Bredenkamp, Gert J. Laubscher, Petrus J. Lourens, et al. (+3)
220 [GO] 2020―Jul―22 Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19? Marta Menegazzi, Rachele Campagnari, Mariarita Bertoldi, Rosalia Crupi, Rosanna Di Paola, Salvatore Cuzzocrea
221 [GO] 2020―Jul―22 A Comprehensive Mapping of the Druggable Cavities within the SARS-CoV-2 Therapeutically Relevant Proteins by Combining Pocket and Docking Searches as Implemented in Pockets 2.0 Silvia Gervasoni, Giulio Vistoli, Carmine Talarico, Candida Manelfi, Andrea R. Beccari, Gabriel Studer, et al. (+4)
222 [GO] 2020―Jul―21 COVID-19: A Review on Diagnosis, Treatment, and Prophylaxis Alessandra Fierabracci, Andrea Arena, Paolo Rossi
223 [GO] 2020―Jul―20 Point-of-Use Rapid Detection of SARS-CoV-2: Nanotechnology-Enabled Solutions for the COVID-19 Pandemic Navid Rabiee, Mojtaba Bagherzadeh, Amir Ghasemi, Hossein Zare, Sepideh Ahmadi, Yousef Fatahi, et al. (+5)
224 [GO] 2020―Jul―20 The COVID-19 Pandemic: Does Our Early Life Environment, Life Trajectory and Socioeconomic Status Determine Disease Susceptibility and Severity? Cyrielle Holuka, Myriam P. Merz, Sara B. Fernandes, Eleftheria G. Charalambous, Snehaa V. Seal, Nathalie Grova, Jonathan D. Turner
225 [GO] 2020―Jul―14 COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks Markus Blaess, Lars Kaiser, Martin Sauer, René Csuk, Hans-Peter Deigner
226 [GO] 2020―Jul―14 Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation Elena Campione, Terenzio Cosio, Luigi Rosa, Caterina Lanna, Stefano Di Girolamo, Roberta Gaziano, et al. (+2)
227 [GO] 2020―Jul―07 Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting Ali Hosseini Rad SM, Alexander D. McLellan
228 [GO] 2020―Jul―06 Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications Alessandro Allegra, Mario Di Gioacchino, Alessandro Tonacci, Caterina Musolino, Sebastiano Gangemi
229 [GO] 2020―Jun―30 Putative Roles for Peptidylarginine Deiminases in COVID-19 Elif Damla Arisan, Pinar Uysal-Onganer, Sigrun Lange
230 [GO] 2020―Jun―30 Body Composition Findings by Computed Tomography in SARS-CoV-2 Patients: Increased Risk of Muscle Wasting in Obesity Paola Gualtieri, Carmela Falcone, Lorenzo Romano, Sebastiano Macheda, Pierpaolo Correale, Pietro Arciello, et al. (+2)
231 [GO] 2020―Jun―30 Influence of Herbal Medicines on HMGB1 Release, SARS-CoV-2 Viral Attachment, Acute Respiratory Failure, and Sepsis. A Literature Review Marzena Wyganowska-Swiatkowska, Michal Nohawica, Katarzyna Grocholewicz, Gerard Nowak
232 [GO] 2020―Jun―26 Betacoronavirus Genomes: How Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic Alejandro Llanes, Carlos M. Restrepo, Zuleima Caballero, Sreekumari Rajeev, Melissa A. Kennedy, Ricardo Lleonart
233 [GO] 2020―Jun―26 SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction Cheorl-Ho Kim
234 [GO] 2020―Jun―23 Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs Tuna Toptan, Sebastian Hoehl, Sandra Westhaus, Denisa Bojkova, Annemarie Berger, Björn Rotter, et al. (+4)
235 [GO] 2020―Jun―23 The Strategic Alliance between Clinical and Molecular Science in the War against SARS-CoV-2, with the Rapid-Diagnostics Test as an Indispensable Weapon for Front Line Doctors Antonio Vittorino Gaddi, Fabio Capello, Leonardo Aluigi, Pier Luigi Antignani, Annapaola Callegaro, Gavino Casu, et al. (+20)
236 [GO] 2020―Jun―02 Cerebrovascular and Neurological Dysfunction under the Threat of COVID-19: Is There a Comorbid Role for Smoking and Vaping? Sabrina Rahman Archie, Luca Cucullo
237 [GO] 2020―May―28 Pulmonary Delivery of Fenretinide: A Possible Adjuvant Treatment In COVID-19 Isabella Orienti, Giovanna Angela Gentilomi, Giovanna Farruggia
238 [GO] 2020―May―28 Broad-Spectrum Coronavirus Fusion Inhibitors to Combat COVID-19 and Other Emerging Coronavirus Diseases Xinling Wang, Shuai Xia, Qian Wang, Wei Xu, Weihua Li, Lu Lu, Shibo Jiang
239 [GO] 2020―May―28 Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection? Francesca Rossi, Chiara Tortora, Maura Argenziano, Alessandra Di Paola, Francesca Punzo
240 [GO] 2020―May―28 Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition Aleix Gimeno, Júlia Mestres-Truyol, María José Ojeda-Montes, Guillem Macip, Bryan Saldivar-Espinoza, Adrià Cereto-Massagué, et al. (+2)
241 [GO] 2020―May―21 Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds André Fischer, Manuel Sellner, Santhosh Neranjan, Martin Smieško, Markus A. Lill
242 [GO] 2020―May―21 Proteasome Inhibitors as a Possible Therapy for SARS-CoV-2 Lucia Longhitano, Daniele Tibullo, Cesarina Giallongo, Giacomo Lazzarino, Nicola Tartaglia, Sara Galimberti, et al. (+3)
243 [GO] 2020―May―21 Smoking-Mediated Upregulation of the Androgen Pathway Leads to Increased SARS-CoV-2 Susceptibility Jaideep Chakladar, Neil Shende, Wei Tse Li, Mahadevan Rajasekaran, Eric Y. Chang, Weg M. Ongkeko
244 [GO] 2020―May―18 The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target Mohamed Abu-Farha, Thangavel Alphonse Thanaraj, Mohammad G. Qaddoumi, Anwar Hashem, Jehad Abubaker, Fahd Al-Mulla
245 [GO] 2020―May―15 Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19 Valentino Clemente, Padraig D’Arcy, Martina Bazzaro
246 [GO] 2020―May―14 COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males? Donato Gemmati, Barbara Bramanti, Maria Luisa Serino, Paola Secchiero, Giorgio Zauli, Veronica Tisato
247 [GO] 2020―May―12 Essential Oils as Antiviral Agents. Potential of Essential Oils to Treat SARS-CoV-2 Infection: An In-Silico Investigation Joyce Kelly R. da Silva, Pablo Luis Baia Figueiredo, Kendall G. Byler, William N. Setzer
248 [GO] 2020―May―11 SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment Marcella Prete, Elvira Favoino, Giacomo Catacchio, Vito Racanelli, Federico Perosa
249 [GO] 2020―May―08 Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity Andrea Picchianti Diamanti, Maria Manuela Rosado, Claudio Pioli, Giorgio Sesti, Bruno Laganà
250 [GO] 2020―May―07 Acute Kidney Injury in SARS-CoV-2 Infection: Direct Effect of Virus on Kidney Proximal Tubule Cells Manoocher Soleimani
251 [GO] 2020―May―04 Hybridization Chain Reactions Targeting the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Tzu-Heng Wu, Chia-Chen Chang, Ching-Hsu Yang, Wei-Yin Lin, Tan Joy Ee, Chii-Wann Lin
252 [GO] 2020―May―04 SARS Unique Domain (SUD) of Severe Acute Respiratory Syndrome Coronavirus Induces NLRP3 Inflammasome-Dependent CXCL10-Mediated Pulmonary Inflammation Young-Sheng Chang, Bo-Han Ko, Jyh-Cherng Ju, Hsin-Hou Chang, Su-Hua Huang, Cheng-Wen Lin
253 [GO] 2020―Apr―28 Functional Role of Dietary Intervention to Improve the Outcome of COVID-19: A Hypothesis of Work Giovanni Messina, Rita Polito, Vincenzo Monda, Luigi Cipolloni, Nunzio Di Nunno, Giulio Di Mizio, et al. (+9)
254 [GO] 2020―Apr―28 Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design Maria Bzówka, Karolina Mitusińska, Agata Raczyńska, Aleksandra Samol, Jack A. Tuszyński, Artur Góra
255 [GO] 2020―Apr―24 COVID-19 and RAS: Unravelling an Unclear Relationship Damiano D’Ardes, Andrea Boccatonda, Ilaria Rossi, Maria Teresa Guagnano, Francesca Santilli, Francesco Cipollone, Marco Bucci
256 [GO] 2020―Apr―24 RT-qPCR Testing of SARS-CoV-2: A Primer Stephen A. Bustin, Tania Nolan
257 [GO] 2020―Apr―23 Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D Sandro La Vignera, Rossella Cannarella, Rosita A. Condorelli, Francesco Torre, Antonio Aversa, Aldo E. Calogero
258 [GO] 2020―Apr―21 COVID-19 Drug Discovery Using Intensive Approaches Ayumu Asai, Masamitsu Konno, Miyuki Ozaki, Chihiro Otsuka, Andrea Vecchione, Takahiro Arai, et al. (+8)
259 [GO] 2020―Apr―21 A Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2 Renfei Lu, Xiuming Wu, Zhenzhou Wan, Yingxue Li, Xia Jin, Chiyu Zhang
260 [GO] 2020―Apr―13 A Review of SARS-CoV-2 and the Ongoing Clinical Trials Yung-Fang Tu, Chian-Shiu Chien, Aliaksandr A. Yarmishyn, Yi-Ying Lin, Yung-Hung Luo, Yi-Tsung Lin, et al. (+6)
261 [GO] 2020―Apr―09 Development of a Novel, Genome Subtraction-Derived, SARS-CoV-2-Specific COVID-19-nsp2 Real-Time RT-PCR Assay and Its Evaluation Using Clinical Specimens Cyril Chik-Yan Yip, Chi-Chun Ho, Jasper Fuk-Woo Chan, Kelvin Kai-Wang To, Helen Shuk-Ying Chan, Sally Cheuk-Ying Wong, et al. (+12)
262 [GO] 2020―Mar―25 Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients? Samir Jawhara


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.011 sec